Kolon Life Science Incorporation operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kolon Life Science Incorporation with three other
companies in this sector in South Korea:
CKD Bio Corp
sales of 106.69 billion Korean Won [US$93.89 million]
of which 100%
was Pharmaceutical Manufacturing),
(124.28 billion Korean Won [US$109.36 million]
Ctc Bio, Incorporation.
(118.99 billion Korean Won [US$104.71 million]
During the year ended December of 2015, sales at
Kolon Life Science Incorporation were 121.18 billion Korean Won (US$106.63 million).
decrease of 7.2%
versus 2014, when the company's sales were 130.63 billion Korean Won.
Contributing to the drop in overall sales was the 11.8% decline
in Pharmaceutical Business, from 57.62 billion Korean Won to 50.84 billion Korean Won.
There were also decreases in sales in
Water Solution (down 9.3% to 31.85 billion Korean Won)
However, these declines were partially offset by the increase in sales of
Environment Material (up 1.6% to 38.49 billion Korean Won)